BeOne Medicines AG (ONC) stock analysis

ONC · BeOne Medicines AG

Latest recorded price: USD 411.29

Sector and industry: Healthcare · Biotechnology

A reliable intrinsic value could not be calculated for ONC; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 55.7%, free cash flow margin 17.6%. The model flags 1 risk signal for this company.

Similar companies in Healthcare